All Stories

  1. Synthesis, Anticancer Evaluation and Molecular Docking of Hexahydroquinoline Derivatives as Mcl-1 Inhibitors and Apoptosis Inducers

    Article • Anti-Cancer Agents in Medicinal Chemistry, July 2022, Bentham Science Publishers

    Professor Subhas S Karki

  2. Synthesis, Cytotoxicity Evaluation and Molecular Docking of Fluorine Containing Hexahydroquinoline-3-Carbonitrile Derivatives

    Article • Current Drug Discovery Technologies, January 2022, Bentham Science Publishers

    Professor Subhas S Karki

  3. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models [Corrigendum]

    Article • International Journal of Nanomedicine, August 2019, Dove Medical Press

    Miss Padma Priya Srinivasan , Professor Subhas S Karki

  4. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models

    Article • International Journal of Nanomedicine, July 2019, Dove Medical Press

    Professor Subhas S Karki, Miss Padma Priya Srinivasan

  5. Pluronic copolymer encapsulated SCR7 as a potential anticancer agent

    Article • Faraday Discussions, January 2015, Royal Society of Chemistry

    Professor Subhas S Karki

  6. Synthesis and evaluation of the biological activity of N′-[2-oxo-1,2 dihydro-3H-indol-3-ylidene] benzohydrazides as potential anticancer agents

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Professor Subhas S Karki

  7. Enhanced Efficacy of Pluronic Copolymer Micelle Encapsulated SCR7 against Cancer Cell Proliferation

    Article • Macromolecular Bioscience, December 2014, Wiley

    Professor Subhas S Karki

  8. Synthesis and antiproliferative activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, October 2014, Elsevier

    Professor Subhas S Karki

  9. 2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: Synthesis, cytotoxic activity and mechanism of action

    Article • European Journal of Medicinal Chemistry, September 2014, Elsevier

    Professor Subhas S Karki, Dr Anil Kumar G N

  10. Synthesis of thiocarbohydrazide and carbohydrazide derivatives

    Article • Medicinal Chemistry Research, August 2013, Springer Science + Business Media

    Professor Subhas S Karki, sreekanth thota

  11. Synthesis, spectroscopic characterization,in vitrocytotoxic

    Article • Journal of Coordination Chemistry, March 2013, Taylor & Francis

    Professor Subhas S Karki, sreekanth thota

  12. New Isatin and Thiophene Derivatives

    Article • Letters in Drug Design & Discovery, December 2012, Bentham Science Publishers

    Professor Subhas S Karki, sreekanth thota

  13. An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression

    Article • Cell, December 2012, Elsevier

    Professor Subhas S Karki

  14. Novel Levamisole Derivative Induces Extrinsic Pathway of Apoptosis in Cancer Cells and Inhibits Tumor Progression in Mice

    Article • PLOS One, September 2012, PLOS

    Professor Subhas S Karki

  15. Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-substituted-hydrazinecarbothioamides

    Article • Medicinal Chemistry Research, August 2012, Springer Science + Business Media

    Professor Subhas S Karki

  16. Ru(II) complexes

    Article • Chinese Chemical Letters, April 2012, Elsevier

    Professor Subhas S Karki, sreekanth thota

  17. Synthesis, spectroscopic characterization, antineoplastic,in vitro-cytotoxic, and antibacterial

    Article • Journal of Coordination Chemistry, February 2012, Taylor & Francis

    Professor Subhas S Karki, sreekanth thota

  18. Synthesis and Biological Evaluation of 5-Formyl-6-arylimidazo(2,1-b)-1,3,4-thiadiazole-2-N-(dimethylaminomethino)sulfonamides as Antitumor Agents

    Article • Arzneimittelforschung, December 2011, Thieme Publishing Group

    Professor Subhas S Karki

  19. ChemInform Abstract: Synthesis and Biological Evaluation of Novel 2-Aralkyl-5-substituted-6-(4′-fluorophenyl)-imidazo[2,1-b] [1,3,4]thiadiazole Derivatives as Potent Anticancer Agents.

    Article • ChemInform, August 2011, Wiley

    Professor Subhas S Karki

  20. Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4′-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents

    Article • European Journal of Medicinal Chemistry, June 2011, Elsevier

    Professor Subhas S Karki

  21. Microwave-assisted synthesis and antimicrobial activity of some imidazo[2,1-b][1,3,4]thiadiazole derivatives

    Article • Medicinal Chemistry Research, May 2011, Springer Science + Business Media

    Professor Subhas S Karki

  22. In vitro cytotoxicity and induction of apoptosis by ruthenium(II) complexes in HL-60 and K-562

    Article • Medicinal Chemistry Research, March 2011, Springer Science + Business Media

    Professor Subhas S Karki

  23. Synthesis, characterization, antitumor, and cytotoxic activity of mononuclear Ru(II) complexes

    Article • Journal of Coordination Chemistry, November 2010, Taylor & Francis

    Professor Subhas S Karki, sreekanth thota

  24. Synthesis and biological evaluation of some stilbene derivatives

    Article • Medicinal Chemistry Research, November 2010, Springer Science + Business Media

    Professor Subhas S Karki

  25. Synthesis and cytostatic evaluation of some 2-(5-substituted-2-oxoindolin-3-ylidene)-N-substituted hydrazine carbothioamide

    Article • Medicinal Chemistry Research, October 2010, Springer Science + Business Media

    Professor Subhas S Karki

  26. Synthesis and biological evaluation of some stilbene-based analogues

    Article • Medicinal Chemistry Research, October 2010, Springer Science + Business Media

    Professor Subhas S Karki

  27. ChemInform Abstract: Synthesis and Biological Evaluation of 5-Formyl-6-arylimidazo(2,1-b)-1,3,4-thiadiazole-2-N- (dimethylaminomethino)sulfonamides as Antitumor Agents.

    Article • ChemInform, June 2010, Wiley

    Professor Subhas S Karki

  28. Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, February 2010, Taylor & Francis

    Professor Subhas S Karki, sreekanth thota

  29. Synthesis, anticancer and cytostatic activity of some 6H-indolo[2,3-b]quinoxalines

    Article • Acta Pharmaceutica, January 2009, De Gruyter

    Professor Subhas S Karki

  30. 1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, October 2008, Taylor & Francis

    Professor Subhas S Karki

  31. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds

    Article • Bioorganic & Medicinal Chemistry, November 2007, Elsevier

    Professor Subhas S Karki, sreekanth thota

  32. Synthesis and anticancer activity of certain mononuclear Ru (II) Complexes

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, January 2006, Taylor & Francis

    Professor Subhas S Karki

  33. Synthesis and pharmacological activities of some mononuclear Ru(II) complexes

    Article • Bioorganic & Medicinal Chemistry, October 2005, Elsevier

    Professor Subhas S Karki

  34. Antineoplastic and Antibacterial Activity of some Mononuclear Ru(II) Complexes

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, April 2004, Taylor & Francis

    Professor Subhas S Karki

  35. Synthesis, Anticancer and Antibacterial Activity of Some Novel Mononuclear Ru(II) Complexes

    Article • Chemical and Pharmaceutical Bulletin, January 2004, Pharmaceutical Society of Japan

    Professor Subhas S Karki

  36. Evaluation of Anti-inflammatory Activity of Chloroform Extract of Bryonia laciniosa in Experimental Animal Models

    Article • Biological and Pharmaceutical Bulletin, January 2003, Pharmaceutical Society of Japan

    Professor Subhas S Karki, Dr Sambathkumar R